Product Offerings
Products:
Licorice Products: Monoammonium Glycyrrhizinate (MAG), Licorice Extract Powder, Licorice Extract Blocks, Glycyrrhiza Flavonoids, Glycyrrhizine R19, Glycyrrhizine R21, 18-β Glycyrrhetinic Acid, Acetyl Glycyrrhetinic Acid
Licorice Products: Monoammonium Glycyrrhizinate (MAG), Licorice Extract Powder, Licorice Extract Blocks, Glycyrrhiza Flavonoids, Glycyrrhizine R19, Glycyrrhizine R21, 18-β Glycyrrhetinic Acid, Acetyl Glycyrrhetinic Acid
Qinghai Lake Pharmaceutical Co., Ltd. was established in 1996 and is located in Xining City, Qinghai Province, China. It is a professional pharmaceutical company integrating R&D, production and sales. The company is committed to providing high-quality licorice products and derivatives to the global pharmaceutical and health care products market through modern process technology and strict quality control systems.
The core business of Qinghai Lake Pharmaceutical is the production and research and development of licorice (Glycyrrhiza) series products. The company utilizes the rich wild licorice resources in Qinghai Province and uses modern extraction processes and technologies to continuously improve the purity and efficacy of its products to meet the needs of different customer groups.
The company focuses on the production and export of licorice extract and its derivatives. Its main products include:
Qinghai Lake Pharmaceutical has a high-level scientific research team and has established a complete R&D center and quality inspection system. The company uses modern extraction technologies, including supercritical carbon dioxide extraction technology, countercurrent extraction technology, and membrane separation technology, to ensure high purity and high efficiency of the product. At the same time, the company continues to optimize the production process and improve the production efficiency and quality stability of its products.
Qinghai Lake Pharmaceutical's products are mainly targeted at the following markets:
The company has passed a number of domestic and foreign certifications to ensure that its products meet the standard requirements of the international market:
As a non-listed company, Qinghai Lake Pharmaceutical's specific financial data has not been made public. However, according to market research and export records, the company's revenue mainly comes from the export business of licorice products. The company's exports to markets such as Europe, America, Japan, and Southeast Asia are growing steadily every year.
Qinghai Lake Pharmaceutical's export data over the past five years shows that its main export products are licorice extract products such as Monoammonium Glycyrrhizinate, Licorice Extract Powder, and Glycyrrhetinic Acid. The company's cooperative relations with international pharmaceutical companies have continued to deepen, and exports have increased year by year.
The company's products have been widely recognized by domestic and foreign customers for their high quality and stability. Especially in the European and American markets, customers speak highly of the purity and safety of Qinghai Lake Pharmaceutical's products.
Qinghai Qinghai Lake Pharmaceutical Co., Ltd. will continue to adhere to the development philosophy of "technology-led, quality-oriented", continuously improve the international competitiveness of its products through innovation and research and development, and provide higher-quality licorice products and services to global customers.